Post Chemotherapy

Chemotherapy, a cornerstone in cancer treatment, is associated with numerous challenges, including extensive treatment durations, frequent medical appointments, and a range of side effects like nausea, fatigue, and significant hair loss. Among these, hair loss—medically referred to as Chemotherapy-Induced Alopecia (CIA)—stands out due to its profound impact on patients’ psychological well-being.

Hair plays a critical role in an individual’s self-image, attractiveness, and personal identity. Consequently, hair loss can deeply affect one’s body image and self-esteem, leading to feelings of distress and diminished confidence during and after treatment. For many undergoing chemotherapy, the experience of CIA becomes a visible stigma of their illness, adding emotional strain to an already challenging journey.

In addressing this distressing side effect, QR678® Neo therapy emerges as a significant breakthrough. Specifically designed to counteract hair loss, QR678® Neo offers a new solution for those suffering from CIA. Its unique formulation, leveraging a blend of growth factors and peptides, targets the underlying mechanisms of hair fall, promoting hair regrowth and restoring scalp health. By providing a “Quick Response” to a previously unmet challenge in cancer care, QR678® Neo not only aids in physical recovery but also supports emotional and psychological healing, helping patients reclaim a sense of normalcy and self-confidence post-chemotherapy.

The following mechanism of chemotherapy causes hair loss:

Toxic Effects on Hair Follicles

Chemotherapy-induced alopecia (CIA) results from the impact of chemotherapy drugs on hair follicles. These drugs target rapidly dividing cells, a characteristic of many cancer cells, but unfortunately, hair follicle cells also divide rapidly and are thus affected by the treatment. This leads to hair loss, which can be one of the most distressing side effects of chemotherapy for many patients.

Cellular Damage

Chemotherapy medications target and disrupt the DNA within hair follicle cells, leading to potential damage. Such cellular disruption can cause hair follicles to shift into a dormant or resting state, culminating in hair loss.

Anagen Effluvium

Chemotherapy treatments impact hair follicles during the anagen, or growth phase, of the hair cycle, resulting in rapid and extensive hair shedding. Hair follicles in the anagen phase are particularly vulnerable as they are in the midst of active hair production, making them more sensitive to chemotherapy's disruptive effects..

Patient-Specific Factors

The extent of hair loss during chemotherapy can vary significantly among individuals, influenced by factors such as age, genetic predisposition, and general health status. This variability means that while some individuals may encounter only slight hair thinning, others might experience extensive or complete hair loss.

Innovative Strategies for Managing Chemotherapy-Induced Hair Loss

Chemotherapy patients face various challenges, including significant hair loss. However, advancements in treatment and care offer effective methods to mitigate this side effect and encourage hair regrowth:

Minoxidil

Recognized for its efficacy in promoting hair regrowth, Minoxidil enhances blood circulation to the follicles, improving nutrient delivery. It is available for topical or oral application.

Scalp Cooling (Cold Cap Therapy)

This method reduces hair loss by cooling the scalp during chemotherapy sessions. The reduced temperature narrows blood vessels, decreasing the chemotherapy drugs' reach to hair follicles.

Low-Level Laser Therapy (LLLT):

FDA-approved for hair growth, LLLT presents a non-invasive option to stimulate hair follicles. Its effectiveness specifically for chemotherapy-induced hair loss is under further exploration.

Hair and Scalp Care

Gentle hair care routines, including the use of mild, fragrance-free products and avoiding damaging treatments, play a vital role in maintaining hair health during and after chemotherapy.

Emerging as a groundbreaking approach, QR678® Neo addresses hair loss with a targeted formulation of growth factors and peptides, akin to those naturally occurring in a healthy scalp. This therapy is designed to significantly enhance hair regrowth and improve scalp health after chemotherapy. QR678® Neo's non-invasive application and proven effectiveness in clinical trials make it a promising option for those seeking to recover from chemotherapy-induced alopecia, offering renewed hope and confidence through restored hair vitality. By incorporating these strategies, patients undergoing chemotherapy can find solace in knowing there are viable options to address hair loss, with QR678® Neo leading the way in innovative, effective treatment.

The QR678® Neo therapy in Post Chemotherapy Hair Loss:

The QR678® Neo therapy stands out as a pioneering solution in the battle against hair loss, particularly following chemotherapy. This advanced hair regrowth treatment is distinguished by its unique blend of growth factors and peptides, offering a novel approach to addressing chemotherapy-induced alopecia. Originating in India, the name QR678® draws inspiration from the concept of “Quick Response,” akin to the QR code’s role in providing immediate access to information. The “678” in Morse Code, symbolizing “there is no answer,” underscores the therapy’s aim to offer a definitive solution to conditions previously deemed untreatable. QR678® Neo is designed to deliver a swift and effective response to post-chemotherapy hair loss, marking a significant milestone in therapeutic advancements for patients seeking to overcome the challenges of alopecia.

Before & After Results

Get Started with QR 678 neo

FAQ's

How is QR678® Neo better than other hair fall treatments?

QR678® Neo consists of a proprietary blend of natural growth factors, identical to those found in a healthy scalp, ensuring its safety for universal application. This precise formulation contains targeted concentrations of specific factors known to promote hair growth. With QR678® Neo, patients experience no side effects. The treatment is administered on an outpatient basis, with visible results emerging as early as eight weeks after commencement. Hear directly from our patients about their experiences with the QR678® Neo hair loss treatment.

How often do I need to repeat QR678® Neo treatment?

QR678® Neo treatments involve 5 to 10 sessions, spaced approximately 2-3 weeks apart. Visible improvements can be observed within a few weeks following the commencement of the therapy. Once optimal results are attained, further injections are unnecessary unless hair loss recurs. This enduring effect is due to QR678® Neo’s capacity to rejuvenate hair follicles. Discover the reasons behind QR678® Neo’s high efficacy in reducing hair loss and enhancing hair regrowth.

What precautions should I take after QR678® Neo treatment?

QR678® Neo offers a safe treatment experience without any side effects, enabling you to continue with your day-to-day activities right after each session. It is recommended to use a mild shampoo at least a day post-treatment and refrain from scratching or rubbing the area treated. If any concerns arise, consult your treatment provider for guidance.

Can QR678® Neo be used after hair transplant?

Utilizing QR678® Neo in conjunction with hair transplant procedures has been shown to yield highly successful outcomes. QR678® Neo enhances hair density more rapidly and mitigates the shedding (catagen loss) of newly transplanted hair. The growth factors present in QR678® Neo contribute to quicker healing and reactivation of dormant hair follicles, thereby:
Enhancing the survival rate of hair follicles. Accelerating the tissue healing and repair process Revitalizing inactive hair follicles and promoting hair regrowth. Boosting the health of existing hair, making it fuller and stronger. QR678® Neo treatments can be administered in several sessions, starting three to four weeks post a successful hair transplant surgery. Additionally, QR678® Neo can be applied prior to hair transplant surgery to minimize the area needing transplantation and further improve the surgical outcomes.

Can genetic hair loss be treated?

Genetic hair loss, often hereditary and observed in both men and women, can indeed be managed effectively if treatment commences early. This type of hair loss, which frequently runs in families, typically follows a distinctive pattern: an M or W shape in men and thinning along the hair part in women. If you have a family history of patterned baldness, it’s crucial to monitor your hair health closely and consult a doctor at the first sign of hair loss.

There are several well-established treatments for genetic hair loss, including:

Topical and Oral Medications: Minoxidil, applied topically, and Finasteride, taken orally, are commonly prescribed to combat hair loss.
Hair Transplantation: Surgical options such as Follicular Unit Transplantation (FUT) and Follicular Unit Extraction (FUE) are effective methods for restoring hair.
Nutritional Supplements: Physicians may recommend hair growth supplements. Key nutrients like Vitamins A, C, and Biotin, along with minerals such as zinc and iron, are known to support hair health and reduce loss attributed to genetic factors.

Treatment option for Chemotherapy induced Alopecia?

Alopecia following chemotherapy is a widespread and emotionally impactful side effect of cancer treatments. The fear of hair loss often deters patients from undergoing necessary therapies. While hair loss from chemotherapy is usually temporary, regrowth can take months or even up to a year. However, recent advancements in treatment can expedite recovery:

Scalp Cooling: An FDA-approved method, particularly for breast cancer patients, scalp cooling can reduce chemotherapy’s impact on hair. It works by narrowing blood vessels in the scalp, lessening the amount of chemotherapy drugs reaching the hair follicles. The process involves a cooling unit that circulates coolant on the scalp, initiated about 30 minutes before chemotherapy begins. Side effects may include mild discomfort, nausea, and dry skin.
Topical Minoxidil: This medication enhances blood flow to the hair follicles, helping to prevent their shrinkage and encouraging hair retention.
QR678® Neo Hair Regrowth Treatment: FDA-approved and safe, QR678® Neo is effective in treating chemotherapy-induced alopecia in both men and women without side effects or discomfort. Clinical trials have demonstrated its efficacy, with results that can last a lifetime.

These treatments offer hope and options for those facing hair loss due to chemotherapy, providing a path to recovery and helping to mitigate one of the most challenging aspects of cancer treatment.